 Source: Palatinate Stock Shutterstock.com BioNTech NASDAQ: BNTX stock is on falling on Monday after the company released poor results for its second quarter of 2022. This saw it report diluted earnings per share of 6.45 euros and revenue of 3.2 billion euros. 